Vol 5, No 6S (2011)

Table of Contents

Editorial

The importance of comorbidity and the usefulness of therapeutic early shift in the management of CML patients
Fabio Stagno
PDF
3-4

Case report

Efficacy of nilotinib as third-line treatment in a patient with very late Chronic Myeloid Leukemia and a possibile cardiologic contraindication
Ester Maria Orlandi, Sara Redaelli
PDF
5-9
Nilotinib early switch efficacy in non-optimal responder CML patient after first line imatinib treatment
Ferdinando Porretto
PDF
11-16
Nilotinib is effective and well tollerate in patients with multiple comorbidities
Carmen Fava, Marco Fizzotti, Giuseppe Saglio, Giovanna Rege-Cambrin
PDF
17-21
Early switch to nilotinib in a case of non-optimal response to imatinib
Alessandra Iurlo, Tommaso Radice, Chiara De Philippis, Manuela Zappa, Mauro Pomati, Agostino Cortelezzi
PDF
23-26